FDA is considering how to deal with the phaseout of chlorofluorocarbons from inhalers, which is only a year away.
All News
Advertisement
Sapropterin approved for phenylketonuria treatment
Advertisement
New oral beta-blocker nebivolol approved by FDA
The Drug Topics time capsule was sealed the ASHP midyear meeting.
A Judge has issued an injunction halting the implementation of the new AMP payment formula for Medicaid.
CMS announces accreditation deadlines for Part B DMEPOS suppliers
Advertisement
Two technology companies have joined together to integrate hospital IT systems.
SAMHSA: 3.1 million young adults have abused OTC cough medicine in their lifetime.
A new report urges sales reps to focus on pharmacy directors, P&T members, and chief medical officers when pitching new products.
Missouri is considering legislation that will let trained psychologists prescribe medications.
Advertisement
Rite Aid to exit Las Vegas market.
Impotent men can now take Cialis on a daily basis.
NACDS, 90 organizations send letter to state Medicaid directors on tamper-resistant Rxs.
Chronic disease patients are more compliant when Rx co-payments decrease.
AAHomecare supports Medicare anti-fraud measures.
CMS announces second round of Medicare DMEPOS competitive bidding program.
FDA warns seven pharmacies that the claims they have made for their bioidentical hormones are unsupported.
William Shields, named CEO of Artomick, a medication management and technology company.
FDA issues warning for bisphosphonates.
According to Consumers Union, drug prices rose at 75% of the Medicare Part D prescription drug plans.
The Centers for Medicare & Medicaid Services proposes a rule to reduce premiums for low-income subsidized patients.
Insulet, DexCom announce development agreement for glucose monitoring.
EMHS, PhRMA partner to improve access to medicine in eastern Maine.
Home Diagnostics signs exclusive co-brand agreement with Rite Aid.
NACDS supports FDA toll- free number for reporting adverse events requirement.
NACDS Foundation awards $140,000 in grants to community pharmacy.
Major drugstore chains report weak December sales.
FDA releases new study findings for ESA use in cancer patients.
Medication therapy management opportunities expand in Ohio.
